首页/数据集/Supplementary Table 3 from Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids

Supplementary Table 3 from Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids

NIAID Data Ecosystem2026-05-26 收录

类器官药物筛选

DNA修复抑制剂反应预测

数据链接：

https://figshare.com/articles/dataset/Supplementary_Table_3_from_Prediction_of_DNA_Repair_Inhibitor_Response_in_Short-Term_Patient-Derived_Ovarian_Cancer_Organoids/22532057 数据链接链接失效反馈

官方服务：

资源简介：

Supplementary Table 3

应用场景：

创建时间：

2018-11-01

类器官药物筛选

精准肿瘤治疗

Precision oncology aims to improve clinical outcome of patients by offering personalized treatment through identifying druggable genomic aberrations within their tumors. This is particularly valid whe

NIAID Data Ecosystem60

High-content, targeted RNA-seq screening in organoids for drug discovery in colorectal cancer

结直肠癌药物

类器官药物筛选

We present TORNADO-seq âa high-throughput, a high-content drug discovery platform that for the first time uses next-generation sequencing (NGS) based, targeted RNA-seq in organoids monitoring the ex

NIAID Data Ecosystem50

Deep Annotation of Donated Chemical Probes (DCP) in Organotypic Human Liver Cultures and Patient-Derived Organoids from Tumor and Normal Colorectum

化学探针表征

类器官药物筛选

Well-characterized small molecules are essential tools for studying the biology and therapeutic relevance of a target protein. However, many compounds reported in the literature and routinely studied

NIAID Data Ecosystem30

Image-based profiling identifies compound induced phenotypes in patient-derived organoids

类器官药物筛选

结直肠癌精准治疗

Patient derived organoids (PDOs) closely resemble individual tumor biology. They are thus promising models for drug discovery and precision medicine. Here, we describe high-throughput imaging and auto

NIAID Data Ecosystem60

Table_2_Organoid drug screening report for a non-small cell lung cancer patient with EGFR gene mutation negativity: A case report and review of the literature.doc

类器官药物筛选

非小细胞肺癌精准治疗

Patients with non-small cell lung cancer (NSCLC) who carry epidermal growth factor receptor (EGFR) mutations can benefit significantly from EGFR tyrosine kinase inhibitors (EGFR TKIs). However, it is

NIAID Data Ecosystem30

Supplementary Table 3 from Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids

资源简介：

相关数据集